Role of the intestinal MALT in pathogenesis of the IgA-nephropathy

被引：0
作者：
Guliaev, Sergei, V [1 ]
Strizhakov, Leonid A. [1 ,2 ]
Chebotareva, Natalia, V [1 ,2 ]
Moiseev, Sergei, V [1 ,2 ]
机构：
[1] Sechenov Univ, Sechenov Moscow State Med Univ 1, Moscow, Russia
[2] Lomonosov Moscow State Univ, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2021年 / 93卷 / 06期
关键词：
immunoglobulin A-nephropathy; immunoglobulin A; aberrant glycosylation of immunoglobulin A; intestinal permeability; MALT; IMMUNE-COMPLEXES; GLYCOSYLATED IGA1; LIVER-DISEASE; PERMEABILITY; PURPURA; ANTIBODIES; EDTA; ENDOTOXEMIA; CHILDREN; ANTIGENS;
D O I：
10.26442/00403660.2021.06.200868
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Modern view on pathogenesis of immunoglobulin (Ig)A-nephropathy and possible relation to intestinal MALT-system activity is presented in the article. Aberrant glycosylation of IgA and increased association of IgA-nephropathy with intestinal diseases or abnormal intestinal permeability are discussed in details. Based on supposed entero-renal pathogenesis of the disease future treatment modalities are considered. Relevant world's literature is cited.
引用
收藏
页码：724 / 728
页数：5
相关论文
共 41 条
  • [11] [ДОБРОНРАВОВ Владимир Александрович DOBRONRAVOV Vladimir A.], 2019, [Нефрология, Nefrologiya], V23, P45
  • [12] A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
    Dong, Ruijuan
    Bai, Ming
    Zhao, Jin
    Wang, Di
    Ning, Xiaoxuan
    Sun, Shiren
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [13] Elaziz MMA, 2018, ACTA GASTRO-ENT BELG, V81, P381
  • [14] Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
    Fellstroem, Bengt C.
    Barratt, Jonathan
    Cook, Heather
    Coppo, Rosanna
    Feehally, John
    de Fijter, Johan W.
    Floege, Juergen
    Hetzel, Gerd
    Jardine, Alan G.
    Locatelli, Francesco
    Maes, Bart D.
    Mercer, Alex
    Ortiz, Fernanda
    Praga, Manuel
    Sorensen, Soren S.
    Tesar, Vladimir
    Del Vecchio, Lucia
    [J]. LANCET, 2017, 389 (10084) : 2117 - 2127
  • [15] The mucosa-kidney axis in IgA nephropathy
    Floege, Juergen
    Feehally, John
    [J]. NATURE REVIEWS NEPHROLOGY, 2016, 12 (03) : 147 - 156
  • [16] INTESTINAL PERMEABILITY IN DERMATITIS-HERPETIFORMIS
    GRIFFITHS, CEM
    MENZIES, IS
    BARRISON, IG
    LEONARD, JN
    FRY, L
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (02) : 147 - 149
  • [17] Guliaev SV, 2018, TERAPEVT ARKH, V90, P109, DOI [10.26442/terarkh20189010109-114, 10.26442/terarkh201890104-114]
  • [18] [Климович Владимир Борисович Klimovich V.B.], 2006, [Медицинская иммунология, Meditsinskaya immunologiya], V8, P483
  • [19] A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
    Lafayette, Richard A.
    Canetta, Pietro A.
    Ravin, Brad H.
    Appel, Gerald B.
    Novak, Jan
    Nath, Karl A.
    Sethi, Sanjeev
    Tumlin, James A.
    Mehta, Kshama
    Hogan, Marie
    Erickson, Stephen
    Julian, Bruce A.
    Leung, Nelson
    Enders, Felicity T.
    Brown, Rhubell
    Knoppova, Barbora
    Hall, Stacy
    Fervenza, Fernando C.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (04): : 1306 - 1313
  • [20] Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease):: Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice
    Launay, P
    Grossetête, B
    Arcos-Fajardo, M
    Gaudin, E
    Torres, SP
    Beaudoin, L
    de Serre, NPM
    Lehuen, A
    Monteiro, RC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) : 1999 - 2009
12345